Please login to the form below

Not currently logged in
Email:
Password:

Toujeo

This page shows the latest Toujeo news and features for those working in and with pharma, biotech and healthcare.

Sanofi reveals positive phase 3 results for long-acting insulin Toujeo

Sanofi reveals positive phase 3 results for long-acting insulin Toujeo

The number of patients experiencing severe hypoglycaemia and who experienced hyperglycaemia with ketosis was numerically lower with Toujeo. ... the current indication for Toujeo to include the treatment of T1D in adolescents and children (six years and

Latest news

More from news
Approximately 10 fully matching, plus 26 partially matching documents found.

Latest Intelligence

  • Going the distance Going the distance

    Following hot on the heels of Afrezza has been Toujeo (insulin glargine), the new basal insulin that will be crucial to moving away from Sanofi's dependence on Lantus. ... We are very much encouraging collaboration, so we are working on pairing the

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics